News & Updates

Pandemic boom in wearable device use bares disparities in healthcare access
Pandemic boom in wearable device use bares disparities in healthcare access
03 Dec 2021 byTristan Manalac

Despite the uptick in digital cardiology care during the coronavirus disease 2019 (COVID-19) pandemic, several key barriers to wearable device use remain, including high costs and limited technology knowledge, according to a recent study.

Pandemic boom in wearable device use bares disparities in healthcare access
03 Dec 2021
Alternative complement pathway upregulated in severe, critical COVID-19
Alternative complement pathway upregulated in severe, critical COVID-19
01 Dec 2021

In patients with severe coronavirus disease 2019 (COVID-19), the leptin and alternative complement pathways are hyperactivated, which in turn might lead to greater inflammation, a new study has found.

Alternative complement pathway upregulated in severe, critical COVID-19
01 Dec 2021
Child abuse increased during COVID-19 lockdown
Child abuse increased during COVID-19 lockdown
30 Nov 2021 byRoshini Claire Anthony

Child abuse rates appear to have increased during the lockdowns imposed to control COVID-19 transmission, according to a study from the US presented at the 2021 American Academy of Pediatrics National Conference & Exhibition (AAP 2021).

Child abuse increased during COVID-19 lockdown
30 Nov 2021
Childhood cancers often misdiagnosed as TB, leads to more deaths
Childhood cancers often misdiagnosed as TB, leads to more deaths
30 Nov 2021

Cancer is frequently misdiagnosed as tuberculosis (TB) in children due to the clinical and radiologic overlap of the two diseases, which then contributes to increased mortality in this population, reveals a recent study.

Childhood cancers often misdiagnosed as TB, leads to more deaths
30 Nov 2021
Repurposing a broad-spectrum antiviral drug may help treat asymptomatic, mild COVID-19
Repurposing a broad-spectrum antiviral drug may help treat asymptomatic, mild COVID-19
29 Nov 2021 byJairia Dela Cruz

The oral antiviral drug umifenovir, which is used to treat influenza, appears to be beneficial in COVID-19 patients who are asymptomatic or with mild symptoms, with a phase III study showing that the drug is well tolerated and can induce viral clearance within 5 days.

Repurposing a broad-spectrum antiviral drug may help treat asymptomatic, mild COVID-19
29 Nov 2021